Katelicidin (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "Katelicidin" in Czech language version.

refsWebsite
Global rank Czech rank
4th place
8th place
2nd place
4th place
11th place
313th place
5th place
3rd place
18th place
99th place

doi.org

dx.doi.org

  • Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. Journal of Leukocyte Biology. January 2004, s. 39–48. DOI 10.1189/jlb.0403147. PMID 12960280. S2CID 14902156. 
  • Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cellular Immunology. November 2012, s. 22–35. DOI 10.1016/j.cellimm.2012.11.009. PMID 23246832. 
  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. March 2006, s. 1770–3. DOI 10.1126/science.1123933. PMID 16497887. S2CID 52869005. Bibcode 2006Sci...311.1770L. 
  • Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proceedings of the National Academy of Sciences of the United States of America. August 1998, s. 9541–6. DOI 10.1073/pnas.95.16.9541. PMID 9689116. 
  • Kościuczuk EM, Lisowski P, Jarczak J, Strzałkowska N, Jóźwik A, Horbańczuk J, Krzyżewski J, Zwierzchowski L, Bagnicka E. Cathelicidins: family of antimicrobial peptides. A review. Molecular Biology Reports. December 2012, s. 10957–70. DOI 10.1007/s11033-012-1997-x. PMID 23065264. 
  • Dosler S, Karaaslan E. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Peptides. December 2014, s. 32–7. DOI 10.1016/j.peptides.2014.09.021. PMID 25285879. 
  • Shaykhiev R, Beisswenger C, Kändler K, Senske J, Püchner A, Damm T, Behr J, Bals R. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. American Journal of Physiology. Lung Cellular and Molecular Physiology. November 2005, s. L842-8. DOI 10.1152/ajplung.00286.2004. PMID 15964896. 
  • Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. The Journal of Experimental Medicine. October 2000, s. 1069–74. DOI 10.1084/jem.192.7.1069. PMID 11015447. 
  • von Haussen J, Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R, Biesterfeld S, Aigner A, Czubayko F, Bals R. The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer. January 2008, s. 12–23. DOI 10.1016/j.lungcan.2007.07.014. PMID 17764778. 
  • Girnita A, Zheng H, Grönberg A, Girnita L, Ståhle M. Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor. Oncogene. January 2012, s. 352–65. DOI 10.1038/onc.2011.239. PMID 21685939. 
  • Koczulla R, von Degenfeld G, Kupatt C, Krötz F, Zahler S, Gloe T, Issbrücker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. The Journal of Clinical Investigation. June 2003, s. 1665–72. DOI 10.1172/JCI17545. PMID 12782669. 
  • Ren SX, Shen J, Cheng AS, Lu L, Chan RL, Li ZJ, Wang XJ, Wong CC, Zhang L, Ng SS, Chan FL, Chan FK, Yu J, Sung JJ, Wu WK, Cho CH. FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. Redakce Nie D. PloS One. 2013-05-20, s. e63641. DOI 10.1371/journal.pone.0063641. PMID 23700428. 
  • Gennaro R, Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers. 2000, s. 31–49. DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9. PMID 10931440. 
  • GALLO, R. L.; KIM, K. J.; BERNFIELD, M. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. The Journal of Biological Chemistry. 1997-05-16, roč. 272, čís. 20, s. 13088–13093. PMID: 9148921. Dostupné online [cit. 2021-01-19]. ISSN 0021-9258. DOI 10.1074/jbc.272.20.13088. PMID 9148921. 
  • HAO, Xue; YANG, Hailong; WEI, Ling. Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate. Amino Acids. 2012-08, roč. 43, čís. 2, s. 677–685. PMID: 22009138. Dostupné online [cit. 2021-01-19]. ISSN 1438-2199. DOI 10.1007/s00726-011-1116-7. PMID 22009138. 
  • ACHANTA, Mallika; SUNKARA, Lakshmi T.; DAI, Gan. Tissue expression and developmental regulation of chicken cathelicidin antimicrobial peptides. Journal of Animal Science and Biotechnology. 2012-05-31, roč. 3, čís. 1, s. 15. PMID: 22958518 PMCID: PMC3436658. Dostupné online [cit. 2021-01-19]. ISSN 2049-1891. DOI 10.1186/2049-1891-3-15. PMID 22958518. 
  • PEEL, E.; CHENG, Y.; DJORDJEVIC, J. T. Cathelicidins in the Tasmanian devil (Sarcophilus harrisii). Scientific Reports. 10 11, 2016, roč. 6, s. 35019. PMID: 27725697 PMCID: PMC5057115. Dostupné online [cit. 2021-01-19]. ISSN 2045-2322. DOI 10.1038/srep35019. PMID 27725697. 
  • Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nature Medicine. August 2007, s. 975–80. DOI 10.1038/nm1616. PMID 17676051. S2CID 23470611. 
  • Reinholz M, Ruzicka T, Schauber J. Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Annals of Dermatology. May 2012, s. 126–35. DOI 10.5021/ad.2012.24.2.126. PMID 22577261. 
  • Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA, Koeffler HP, Thadhani R; CAMARGO. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clinical Infectious Diseases. February 2009, s. 418–24. DOI 10.1086/596314. PMID 19133797. 
  • Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. January 2002, s. 389–95. DOI 10.1038/415389a. PMID 11807545. S2CID 205028607. Bibcode 2002Natur.415..389Z. 
  • Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. Journal of Molecular Medicine. May 2010, s. 441–50. DOI 10.1007/s00109-010-0590-9. PMID 20119827. 
  • de Breij A, Riool M, Cordfunke RA, Malanovic N, de Boer L, Koning RI, Ravensbergen E, Franken M, van der Heijde T, Boekema BK, Kwakman PH, Kamp N, El Ghalbzouri A, Lohner K, Zaat SA, Drijfhout JW, Nibbering PH. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Science Translational Medicine. January 2018, s. eaan4044. DOI 10.1126/scitranslmed.aan4044. PMID 29321257. 
  • Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. International Journal of Molecular Sciences. March 2019, s. 1475. DOI 10.3390/ijms20061475. PMID 30909615. 

harvard.edu

adsabs.harvard.edu

nih.gov

ncbi.nlm.nih.gov

  • Dostupné online. 
  • Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. Journal of Leukocyte Biology. January 2004, s. 39–48. DOI 10.1189/jlb.0403147. PMID 12960280. S2CID 14902156. 
  • Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cellular Immunology. November 2012, s. 22–35. DOI 10.1016/j.cellimm.2012.11.009. PMID 23246832. 
  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. March 2006, s. 1770–3. DOI 10.1126/science.1123933. PMID 16497887. S2CID 52869005. Bibcode 2006Sci...311.1770L. 
  • Bals R, Wang X, Zasloff M, Wilson JM. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proceedings of the National Academy of Sciences of the United States of America. August 1998, s. 9541–6. DOI 10.1073/pnas.95.16.9541. PMID 9689116. 
  • Kościuczuk EM, Lisowski P, Jarczak J, Strzałkowska N, Jóźwik A, Horbańczuk J, Krzyżewski J, Zwierzchowski L, Bagnicka E. Cathelicidins: family of antimicrobial peptides. A review. Molecular Biology Reports. December 2012, s. 10957–70. DOI 10.1007/s11033-012-1997-x. PMID 23065264. 
  • Dosler S, Karaaslan E. Inhibition and destruction of Pseudomonas aeruginosa biofilms by antibiotics and antimicrobial peptides. Peptides. December 2014, s. 32–7. DOI 10.1016/j.peptides.2014.09.021. PMID 25285879. 
  • Shaykhiev R, Beisswenger C, Kändler K, Senske J, Püchner A, Damm T, Behr J, Bals R. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. American Journal of Physiology. Lung Cellular and Molecular Physiology. November 2005, s. L842-8. DOI 10.1152/ajplung.00286.2004. PMID 15964896. 
  • Chen Q, Schmidt AP, Anderson GM, Wang JM, Wooters J, Oppenheim JJ, Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. The Journal of Experimental Medicine. October 2000, s. 1069–74. DOI 10.1084/jem.192.7.1069. PMID 11015447. 
  • von Haussen J, Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R, Biesterfeld S, Aigner A, Czubayko F, Bals R. The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. Lung Cancer. January 2008, s. 12–23. DOI 10.1016/j.lungcan.2007.07.014. PMID 17764778. 
  • Girnita A, Zheng H, Grönberg A, Girnita L, Ståhle M. Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor. Oncogene. January 2012, s. 352–65. DOI 10.1038/onc.2011.239. PMID 21685939. 
  • Koczulla R, von Degenfeld G, Kupatt C, Krötz F, Zahler S, Gloe T, Issbrücker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. The Journal of Clinical Investigation. June 2003, s. 1665–72. DOI 10.1172/JCI17545. PMID 12782669. 
  • Ren SX, Shen J, Cheng AS, Lu L, Chan RL, Li ZJ, Wang XJ, Wong CC, Zhang L, Ng SS, Chan FL, Chan FK, Yu J, Sung JJ, Wu WK, Cho CH. FK-16 derived from the anticancer peptide LL-37 induces caspase-independent apoptosis and autophagic cell death in colon cancer cells. Redakce Nie D. PloS One. 2013-05-20, s. e63641. DOI 10.1371/journal.pone.0063641. PMID 23700428. 
  • Gennaro R, Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers. 2000, s. 31–49. DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.0.CO;2-9. PMID 10931440. 
  • GALLO, R. L.; KIM, K. J.; BERNFIELD, M. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. The Journal of Biological Chemistry. 1997-05-16, roč. 272, čís. 20, s. 13088–13093. PMID: 9148921. Dostupné online [cit. 2021-01-19]. ISSN 0021-9258. DOI 10.1074/jbc.272.20.13088. PMID 9148921. 
  • HAO, Xue; YANG, Hailong; WEI, Ling. Amphibian cathelicidin fills the evolutionary gap of cathelicidin in vertebrate. Amino Acids. 2012-08, roč. 43, čís. 2, s. 677–685. PMID: 22009138. Dostupné online [cit. 2021-01-19]. ISSN 1438-2199. DOI 10.1007/s00726-011-1116-7. PMID 22009138. 
  • ACHANTA, Mallika; SUNKARA, Lakshmi T.; DAI, Gan. Tissue expression and developmental regulation of chicken cathelicidin antimicrobial peptides. Journal of Animal Science and Biotechnology. 2012-05-31, roč. 3, čís. 1, s. 15. PMID: 22958518 PMCID: PMC3436658. Dostupné online [cit. 2021-01-19]. ISSN 2049-1891. DOI 10.1186/2049-1891-3-15. PMID 22958518. 
  • PEEL, E.; CHENG, Y.; DJORDJEVIC, J. T. Cathelicidins in the Tasmanian devil (Sarcophilus harrisii). Scientific Reports. 10 11, 2016, roč. 6, s. 35019. PMID: 27725697 PMCID: PMC5057115. Dostupné online [cit. 2021-01-19]. ISSN 2045-2322. DOI 10.1038/srep35019. PMID 27725697. 
  • Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nature Medicine. August 2007, s. 975–80. DOI 10.1038/nm1616. PMID 17676051. S2CID 23470611. 
  • Reinholz M, Ruzicka T, Schauber J. Cathelicidin LL-37: an antimicrobial peptide with a role in inflammatory skin disease. Annals of Dermatology. May 2012, s. 126–35. DOI 10.5021/ad.2012.24.2.126. PMID 22577261. 
  • Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA, Koeffler HP, Thadhani R; CAMARGO. Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clinical Infectious Diseases. February 2009, s. 418–24. DOI 10.1086/596314. PMID 19133797. 
  • Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. January 2002, s. 389–95. DOI 10.1038/415389a. PMID 11807545. S2CID 205028607. Bibcode 2002Natur.415..389Z. 
  • Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. Journal of Molecular Medicine. May 2010, s. 441–50. DOI 10.1007/s00109-010-0590-9. PMID 20119827. 
  • de Breij A, Riool M, Cordfunke RA, Malanovic N, de Boer L, Koning RI, Ravensbergen E, Franken M, van der Heijde T, Boekema BK, Kwakman PH, Kamp N, El Ghalbzouri A, Lohner K, Zaat SA, Drijfhout JW, Nibbering PH. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Science Translational Medicine. January 2018, s. eaan4044. DOI 10.1126/scitranslmed.aan4044. PMID 29321257. 
  • Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. International Journal of Molecular Sciences. March 2019, s. 1475. DOI 10.3390/ijms20061475. PMID 30909615. 

pubmed.ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

  • Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. Journal of Leukocyte Biology. January 2004, s. 39–48. DOI 10.1189/jlb.0403147. PMID 12960280. S2CID 14902156. 
  • Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. March 2006, s. 1770–3. DOI 10.1126/science.1123933. PMID 16497887. S2CID 52869005. Bibcode 2006Sci...311.1770L. 
  • Yamasaki K, Di Nardo A, Bardan A, Murakami M, Ohtake T, Coda A, Dorschner RA, Bonnart C, Descargues P, Hovnanian A, Morhenn VB, Gallo RL. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nature Medicine. August 2007, s. 975–80. DOI 10.1038/nm1616. PMID 17676051. S2CID 23470611. 
  • Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. January 2002, s. 389–95. DOI 10.1038/415389a. PMID 11807545. S2CID 205028607. Bibcode 2002Natur.415..389Z. 

worldcat.org